TFF Pharmaceuticals, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
TFFP on Nasdaq
Industry
Pharmaceutical Preparations
Location
2600 Via Fortuna, Suite 360, Austin, Texas

There are no Buy or Sell transactions made by insiders since 9/12/2023

TFF Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Carlson Capital L P 10%+ Owner $4.2M Aug 15, 2023
Malcolm Fairbairn Director $520K May 19, 2021
Harlan F. Weisman President and CEO, Director $347K Jul 3, 2024
Zamaneh Mikhak Chief Medical Officer $61K Jul 3, 2024
Robert S. Mills Director $25K Jul 3, 2024
Kirk Allen Coleman Chief Financial Officer $22.1K Jul 3, 2024
Stephen Rocamboli Director $17.2K Jul 3, 2024
Glenn R. Mattes President and CEO, Director $16.8K May 16, 2022
Brandi Roberts Director $11.2K Jul 3, 2024
Catherine C. Lee Director $2.01K Jul 3, 2024
Thomas B. King Director $1.84K Jul 3, 2024
Michael Patane Director $1.39K Apr 18, 2024
Christopher Cano Chief Operating Officer Sep 22, 2021
Randy H. Thurman Director Sep 29, 2022
Fletcher Aaron G.L. Director Dec 29, 2022

Recent Insider Transactions by Companies or Individuals for TFF Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.